首页 | 本学科首页   官方微博 | 高级检索  
     


SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists
Authors:Díaz Nuria  Benvenga Mark  Emmerson Paul  Favors Ryan  Mangold Michael  McKinzie Jamie  Patel Nita  Peters Steven  Quimby Steven  Shannon Harlan  Siegel Miles  Statnick Michael  Thomas Elizabeth  Woodland Joseph  Surface Peggy  Mitch Charles
Affiliation:Discovery Research, Eli Lilly and Company, Indianapolis, IN 46285, USA. diaz_nuria@lilly.com
Abstract:The phenolic hydroxy group of opiate-derived ligands is of known importance for biological activity. We have developed a SAR study around LY255582 by comparing the effect of the hydroxy group in the 2- and 4-position of the phenyl ring. Also, we have proved that the 3-position of the phenyl ring is optimal for opioid activity. Furthermore, we have successfully replaced the hydroxy group in LY255582 by carbamate and carboxamide groups. The new analogs have high affinity for the opioid receptors comparable to the corresponding phenol. Carboxamide analog 12 has an improved metabolism profile and proved to be efficacious in in vivo studies.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号